Abiopharma

News list

Director Watson Lucas E 🟢 acquired 288 shares (2 derivative) of W.W. GRAINGER, INC. (GWW) Transaction Date: Apr 29, 2026 | Filing ID: 000004

Full text

News bot May 1, 2026, 9:19 p.m.
🔍 Watson Lucas E (Director)

Company: W.W. GRAINGER, INC. (GWW)

Report Date: 2026-04-29
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 2
- Holdings reported: 1
- Total shares acquired: 288
- Total shares held: 157
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-29 | Code: H | nature_of_ownership: Held in the Watson Trust. | shares_owned_after: 157.00 | Footnotes: F1
- Acquired 176 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,887.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
- Acquired 112 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,999.00 | transaction_form_type: 4 | Footnotes: F2, F4, F3, F3
Footnotes:
- F1: Held in the the Lucas E. Watson Trust - 2025, of which the reporting person is the trustee.
- F2: 1-for-1
- F3: The deferred stock units are expected to settle in shares of common stock on a one-for-one basis following end of service as a director.
- F4: The reporting person received deferred stock units in lieu of cash compensation for service on the board of directors.